Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade c hiv-1 envelopes

Virology

Volumn 475, Issue , 2015, Pages 37-45

  Asmal, Mohammed ^a,g   Luedemann, Corinne ^a   Lavine, Christy L ^a   Mach, Linh V ^a   Balachandran, Harikrishnan ^a   Brinkley, Christie ^c   Denny, Thomas N ^c   Lewis, Mark G ^d   Anderson, Hanne ^d   Pal, Ranajit ^e   Sok, Devin ^f   Le, Khoa ^f   Pauthner, Matthias ^f   Hahn, Beatrice H ^b   Shaw, George M ^b   Seaman, Michael S ^a   Letvin, Norman L ^b   Burton, Dennis R ^f   Sodroski, Joseph G ^a   Haynes, Barton F ^c   Santra, Sampa ^a   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BIOQUAL INC   (United States)

^e ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

^g VERTEX PHARMACEUTICALS   (United States)

Author keywords

HIV 1 Clade C; Mucosal transmission; SHIV; Transmitted founder Env

Indexed keywords

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE C; NONHUMAN; NUCLEOTIDE SEQUENCE; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENVELOPE; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS TRANSMISSION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MUTATION; PHYLOGENY; PHYSIOLOGY; VIREMIA; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

VIRUS ENVELOPE PROTEIN;

ANIMALS; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HIV-1; HUMANS; MUTATION; PHYLOGENY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS; VIREMIA;

EID: 84912544398     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.10.032     Document Type: Article

References (37)

1. Abrahams M.R., Anderson J.A., Giorgi E.E., Seoighe C., Mlisana K., Ping L.H., Athreya G.S., Treurnicht F.K., Keele B.F., Wood N., Salazar-Gonzalez J.F., Bhattacharya T., Chu H., Hoffman I., Galvin S., Mapanje C., Kazembe P., Thebus R., Fiscus S., Hide W., Cohen M.S., Karim S.A., Haynes B.F., Shaw G.M., Hahn B.H., Korber B.T., Swanstrom R., Williamson C., Team C.A.I.S. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J. Virol. 2009, 83:3556-3567. Center for, H.I.V.A.V.I.C.
2. Barouch D.H., Santra S., Schmitz J.E., Kuroda M.J., Fu T.M., Wagner W., Bilska M., Craiu A., Zheng X.X., Krivulka G.R., Beaudry K., Lifton M.A., Nickerson C.E., Trigona W.L., Punt K., Freed D.C., Guan L., Dubey S., Casimiro D., Simon A., Davies M.E., Chastain M., Strom T.B., Gelman R.S., Montefiori D.C., Lewis M.G., Emini E.A., Shiver J.W., Letvin N.L. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 2000, 290:486-492.
3. Cayabyab M., Rohne D., Pollakis G., Mische C., Messele T., Abebe A., Etemad-Moghadam B., Yang P., Henson S., Axthelm M., Goudsmit J., Letvin N.L., Sodroski J. Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate. AIDS Res. Human Retrovir. 2004, 20:27-40.
4. Chen Z., Huang Y., Zhao X., Skulsky E., Lin D., Ip J., Gettie A., Ho D.D. Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina). J. Virol. 2000, 74:6501-6510.
5. Del Prete G.Q., Ailers B., Moldt B., Keele B.F., Estes J.D., Rodriguez A., Sampias M., Oswald K., Fast R., Trubey C.M., Chertova E., Smedley J., LaBranche C.C., Montefiori D.C., Burton D.R., Shaw G.M., Markowitz M., Piatak M., Jr., KewalRamani V.N., Bieniasz P.D., Lifson J.D., Hatziioannou T. Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins. Cell Host Microbe 2014, 16:412-418.
6. Fiebig E.W., Wright D.J., Rawal B.D., Garrett P.E., Schumacher R.T., Peddada L., Heldebrant C., Smith R., Conrad A., Kleinman S.H., Busch M.P. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. Aids 2003, 17:1871-1879.
7. Florese R.H., Demberg T., Xiao P., Kuller L., Larsen K., Summers L.E., Venzon D., Cafaro A., Ensoli B., Robert-Guroff M. Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. J. Immunol. 2009, 182:3718-3727.
8. Haim H., Strack B., Kassa A., Madani N., Wang L., Courter J.R., Princiotto A., McGee K., Pacheco B., Seaman M.S., Smith A.B., Sodroski J. Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivity. PLoS Pathog. 2011, 7:e1002101.
9. Harouse J.M., Gettie A., Tan R.C., Blanchard J., Cheng-Mayer C. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 1999, 284:816-819.
10. Hessell A.J., Poignard P., Hunter M., Hangartner L., Tehrani D.M., Bleeker W.K., Parren P.W., Marx P.A., Burton D.R. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nat. Med. 2009, 15:951-954.
11. Hidajat R., Xiao P., Zhou Q., Venzon D., Summers L.E., Kalyanaraman V.S., Montefiori D.C., Robert-Guroff M. Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques. J. Virol. 2009, 83:791-801.
12. Humbert M., Rasmussen R.A., Song R., Ong H., Sharma P., Chenine A.L., Kramer V.G., Siddappa N.B., Xu W., Else J.G., Novembre F.J., Strobert E., O'Neil S.P., Ruprecht R.M. SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys. Retrovirology 2008, 5:94.
13. Igarashi T., Donau O.K., Imamichi H., Dumaurier M.J., Sadjadpour R., Plishka R.J., Buckler-White A., Buckler C., Suffredini A.F., Lane H.C., Moore J.P., Martin M.A. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages. J. Virol. 2003, 77:13042-13052.
14. Karlsson G.B., Halloran M., Li J., Park I.W., Gomila R., Reimann K.A., Axthelm M.K., Iliff S.A., Letvin N.L., Sodroski J. Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys. J. Virol. 1997, 71:4218-4225.
15. Keele B.F., Giorgi E.E., Salazar-Gonzalez J.F., Decker J.M., Pham K.T., Salazar M.G., Sun C., Grayson T., Wang S., Li H., Wei X., Jiang C., Kirchherr J.L., Gao F., Anderson J.A., Ping L.H., Swanstrom R., Tomaras G.D., Blattner W.A., Goepfert P.A., Kilby J.M., Saag M.S., Delwart E.L., Busch M.P., Cohen M.S., Montefiori D.C., Haynes B.F., Gaschen B., Athreya G.S., Lee H.Y., Wood N., Seoighe C., Perelson A.S., Bhattacharya T., Korber B.T., Hahn B.H., Shaw G.M. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 2008, 105:7552-7557.
16. Letvin N.L., Rao S.S., Montefiori D.C., Seaman M.S., Sun Y., Lim S.Y., Yeh W.W., Asmal M., Gelman R.S., Shen L., Whitney J.B., Seoighe C., Lacerda M., Keating S., Norris P.J., Hudgens M.G., Gilbert P.B., Buzby A.P., Mach L.V., Zhang J., Balachandran H., Shaw G.M., Schmidt S.D., Todd J.P., Dodson A., Mascola J.R., Nabel G.J. Immune and genetic correlates of vaccine protection against mucosal infection by SIV in monkeys. Sci. Transl. Med.. 81ra36 2011, 3.
17. McGee K., Haim H., Korioth-Schmitz B., Espy N., Javanbakht H., Letvin N., Sodroski J. Selection of low envelope glycoprotein reactivity to soluble CD4 and cold during simian-human immunodeficiency virus infection of rhesus macaques. J. Virol. 2014, 88:21-40.
18. Mikell I., Sather D.N., Kalams S.A., Altfeld M., Alter G., Stamatatos L. Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog. 2011, 7:e1001251.
19. Montefiori D.C. Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Current Protocols in Immunology 2005, (Chapter 12, Unit 12 11). J.E. Coligan (Ed.).
20. Moore P.L., Ranchobe N., Lambson B.E., Gray E.S., Cave E., Abrahams M.R., Bandawe G., Mlisana K., Abdool Karim S.S., Williamson C., Morris L., Study C., Immunology N.C.f.H.A.V. Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog. 2009, 5:e1000598.
21. Nishimura Y., Igarashi T., Donau O.K., Buckler-White A., Buckler C., Lafont B.A., Goeken R.M., Goldstein S., Hirsch V.M., Martin M.A. Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses. Proc. Natl. Acad. Sci. USA 2004, 101:12324-12329.
22. Pahar B., Wang X., Dufour J., Lackner A.A., Veazey R.S. Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3). Virology 2007, 363:36-47.
23. Pal R., Taylor B., Foulke J.S., Woodward R., Merges M., Praschunus R., Gibson A., Reitz M. Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1 Ba-L. J. Acquir. Immune Defic. Syndr. 2003, 33:300-307.
24. Parren P.W., Marx P.A., Hessell A.J., Luckay A., Harouse J., Cheng-Mayer C., Moore J.P., Burton D.R. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 2001, 75:8340-8347.
25. Parrish N.F., Wilen C.B., Banks L.B., Iyer S.S., Pfaff J.M., Salazar-Gonzalez J.F., Salazar M.G., Decker J.M., Parrish E.H., Berg A., Hopper J., Hora B., Kumar A., Mahlokozera T., Yuan S., Coleman C., Vermeulen M., Ding H., Ochsenbauer C., Tilton J.C., Permar S.R., Kappes J.C., Betts M.R., Busch M.P., Gao F., Montefiori D., Haynes B.F., Shaw G.M., Hahn B.H., Doms R.W. Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7. PLoS Pathog. 2012, 8:e1002686.
26. Reimann K.A., Li J.T., Veazey R., Halloran M., Park I.W., Karlsson G.B., Sodroski J., Letvin N.L. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 1996, 70:6922-6928.
27. Reimann K.A., Li J.T., Voss G., Lekutis C., Tenner-Racz K., Racz P., Lin W., Montefiori D.C., Lee-Parritz D.E., Lu Y., Collman R.G., Sodroski J., Letvin N.L. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J. Virol. 1996, 70:3198-3206.
28. Ren W., Mumbauer A., Gettie A., Seaman M.S., Russell-Lodrigue K., Blanchard J., Westmoreland S., Cheng-Mayer C. Generation of lineage-related, mucosally transmissible subtype C R5 simian-human immunodeficiency viruses capable of AIDS development, induction of neurological disease, and coreceptor switching in rhesus macaques. J. Virol. 2013, 87:6137-6149.
29. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Paris R., Premsri N., Namwat C., de Souza M., Adams E., Benenson M., Gurunathan S., Tartaglia J., McNeil J.G., Francis D.P., Stablein D., Birx D.L., Chunsuttiwat S., Khamboonruang C., Thongcharoen P., Robb M.L., Michael N.L., Kunasol P., Kim J.H., Investigators M.-T. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 2009, 361:2209-2220.
30. Sarzotti-Kelsoe M., Bailer R.T., Turk E., Lin C.L., Bilska M., Greene K.M., Gao H., Todd C.A., Ozaki D.A., Seaman M.S., Mascola J.R., Montefiori D.C. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. J. Immunol. Methods 2013, 409:131-146.
31. Sato S., Johnson W. Antibody-mediated neutralization and simian immunodeficiency virus models of HIV/AIDS. Current HIV Res. 2007, 5:594-607.
32. Seaman M.S., Janes H., Hawkins N., Grandpre L.E., Devoy C., Giri A., Coffey R.T., Harris L., Wood B., Daniels M.G., Bhattacharya T., Lapedes A., Polonis V.R., McCutchan F.E., Gilbert P.B., Self S.G., Korber B.T., Montefiori D.C., Mascola J.R. Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J. Virol. 2010, 84:1439-1452.
33. Siddappa N.B., Song R., Kramer V.G., Chenine A.L., Velu V., Ong H., Rasmussen R.A., Grisson R.D., Wood C., Zhang H., Kankasa C., Amara R.R., Else J.G., Novembre F.J., Montefiori D.C., Ruprecht R.M. Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection. J. Virol. 2009, 83:1422-1432.
34. Song R.J., Chenine A.L., Rasmussen R.A., Ruprecht C.R., Mirshahidi S., Grisson R.D., Xu W., Whitney J.B., Goins L.M., Ong H., Li P.L., Shai-Kobiler E., Wang T., McCann C.M., Zhang H., Wood C., Kankasa C., Secor W.E., McClure H.M., Strobert E., Else J.G., Ruprecht R.M. Molecularly cloned SHIV-1157ipd3N4: a highly replication-competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env. J. Virol. 2006, 80:8729-8738.
35. Tan R.C., Harouse J.M., Gettie A., Cheng-Mayer C. In vivo adaptation of SHIV(SF162): chimeric virus expressing a NSI, CCR5-specific envelope protein. J. Med. Primatol. 1999, 28:164-168.
36. van Gils M.J., Bunnik E.M., Boeser-Nunnink B.D., Burger J.A., Terlouw-Klein M., Verwer N., Schuitemaker H. Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies. J. Virol. 2011, 85:6986-6995.
37. Yeh W.W., Rahman I., Hraber P., Coffey R.T., Nevidomskyte D., Giri A., Asmal M., Miljkovic S., Daniels M., Whitney J.B., Keele B.F., Hahn B.H., Korber B.T., Shaw G.M., Seaman M.S., Letvin N.L. Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys. J. Virol. 2010, 84:6018-6032.